A Capsida scientist at work in the company’s laboratory in Thousand Oaks. (courtesy photo) Thousand Oaks-based Capsida Biotherapeutics has one goal in mind as the company enters its third year out of stealth mode: to develop treatments for people with serious genetic diseases leveraging its gene therapy technology. And, following yet another partnership with a…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
